NCT05052476 (BACTECOLIC) is a NA clinical trial of Bactecal® D Liquid in Colic, sponsored by Astel Medica.

Who is sponsoring NCT05052476?

NCT05052476 is sponsored by Astel Medica.

What drugs are being tested in NCT05052476?

Interventions in NCT05052476: Bactecal® D Liquid.

Is NCT05052476 still recruiting?

NCT05052476 is currently completed. Last updated 28 November 2023.

Last reviewed 2023-11-28 · How we verify

NCT05052476: BACTECOLIC

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

First Line Dose-efficacy Study of Bactecal® D Liquid for Infant Colic

Completed NA Last updated 28 November 2023

What this trial tests

NA trial testing Bactecal® D Liquid in Colic in 68 participants. Completed in 16 October 2023.

Timeline

8 April 2022

Primary endpoint
8 October 2023

16 October 2023

Quick facts

Lead sponsor	Astel Medica
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	68
Start date	8 April 2022
Primary completion	8 October 2023
Estimated completion	16 October 2023
Sites	1 location across Belgium

Drugs / interventions tested

Bactecal® D Liquid

Conditions studied

Colic — all drugs for Colic →

Sponsor

Astel Medica

Who can join

Adults 2 Weeks to 8 Weeks, any sex, with Colic. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This randomized, open label, dose-response study will be realized at the first line with Bactecal® D Liquid. The objective is to investigate Bactecal® D Liquid in the context of infantile colics. The patients will be randomized into two arms, A and B, in function of the intervention dose. The quality of life of te parents as well as the daily median crying time and the number of daily crying will be assessed.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

A synbiotic mixture for the management of infantile colic: A randomized trial.
Delcourt H, Huysentruyt K, Vandenplas Y. · · 2024 · cited 1× · PMID 39557731 · DOI 10.1007/s00431-024-05860-5

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05052476 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Astel Medica
Last refreshed: 28 November 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05052476.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing